Strategies for Oncology Providers Amid the Ever-Increasing Drug Shortages

Cancer drug shortages have reached an unprecedented level, posing significant challenges for patients and healthcare providers. At a recent National Comprehensive Cancer Network (NCCN) meeting, experts highlighted that the shortages are the “worst it's ever been.” This crisis is affecting a wide range of drugs, including those vital for chemotherapy, supportive care and symptom management.

The impact of these shortages is profound. Patients may face delays in treatment, which can adversely affect their prognosis. In some cases, oncologists are forced to substitute drugs, potentially compromising the effectiveness of treatment. This situation also increases the stress and uncertainty for patients and their families, adding emotional strain to what is already a difficult journey.  

The causes of these shortages are multifaceted, involving supply chain issues, manufacturing problems and economic factors such as low profitability of generic drugs. In response, there have been calls for more robust governmental and industry action to stabilize drug supplies and ensure that critical medications are available when needed.

Cancer drug shortages are expected to intensify due to low profitability of generic drugs. This can force providers to prescribe alternative therapy which is often more expensive. Additionally, this not only impacts pharmacy budgets but also places a significant financial burden on patients.  

To help patients manage these higher costs, patient assistance programs become crucial. These programs, typically offered by pharmaceutical companies and charitable foundations, aim to provide financial assistance or medications at no cost to those who qualify. Providers play a vital role in this process by:

1. Proactively identifying eligible patients: Providers can assist by proactively identifying patients who are eligible for financial aid through the use of automation.

2. Navigating assistance programs: Providers can help patients navigate the complex landscape of assistance enrollment through technology. This includes securing necessary documents, funding capacity, securing consent, and award coordination.

3. Educating on alternative options: Educate patients about all available therapeutic options, including those that might be more cost-effective.

By taking these steps providers can mitigate some challenges with drug shortages and alternative high medication costs, ensuring patients receive treatment without financial distress.